Showing results (171-180 of 294) with videos related to

Sort By:
Pageof 30
Nature Medicine|September 4, 2012
Multigenerational epigenetic adaptation of the hepatic wound-healing responseMüjdat Zeybel, Timothy Hardy, Yi K Wong, et al.
Biomedicines|December 24, 2021
Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver DiseaseAnne Linde Mak, Jenny Lee, Anne-Marieke van Dijk, et al.
JHEP Reports : Innovation in Hepatology|August 11, 2020
Cost of non-alcoholic steatohepatitis in Europe and the USA: The GAIN studyJamie O'Hara, Alan Finnegan, Harpal Dhillon, et al.
European Journal of Clinical Pharmacology|June 4, 2014
N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient groupChing-Soon Ng, Abul Hasnat, Abdullah Al Maruf, et al.
Gastroenterology|February 14, 2016
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis WorseningVlad Ratziu, Stephen A Harrison, Sven Francque, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 20, 2019
Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic SteatohepatitisZobair M Younossi, Maria Stepanova, Quentin M Anstee, et al.
Nature Reviews. Gastroenterology & Hepatology|July 17, 2024
A roadmap for clinical trials in MASH-related compensated cirrhosisJuan M Pericàs, Quentin M Anstee, Salvador Augustin, et al.
Cardiovascular Diabetology|April 8, 2015
Cardiac structure and function are altered in type 2 diabetes and non-alcoholic fatty liver disease and associate with glycemic controlSophie Cassidy, Kate Hallsworth, Christian Thoma, et al.
Hepatology (Baltimore, Md.)|November 2, 2010
Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicityJoanna D Stewart, Rita Horvath, Enrico Baruffini, et al.
Diabetologia|June 30, 2017
Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory studyElina Isokuortti, You Zhou, Markku Peltonen, et al.
Pageof 30